NAVCO Pharmaceuticals Inc (TSE:NAV) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
NAVCO Pharmaceuticals Inc., a company specializing in nanotechnology for health products, has granted 3.9 million stock options to its officers, directors, and consultants at $0.05 per share, exercisable over ten years. These options, part of the company’s 2018 stock option plan, vest immediately to aid in the growth of NAVCO, which is focused on innovative defenses against pathogens in various markets, including human health and veterinary services.
For further insights into TSE:NAV stock, check out TipRanks’ Stock Analysis page.